LEVI STRAUSS & CO Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Levi Strauss & Co quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q4 2016 to Q3 2024.
  • Levi Strauss & Co Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending August 25, 2024 was $577M, a 96% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $577M +$283M +96% Aug 25, 2024 10-Q 2024-10-02
Q2 2024 $641M +$170M +36% May 26, 2024 10-Q 2024-06-26
Q1 2024 $517M +$195M +60.6% Feb 25, 2024 10-Q 2024-04-03
Q4 2023 $399M -$30.9M -7.19% Nov 26, 2023 10-Q 2024-10-02
Q3 2023 $295M -$205M -41% Aug 27, 2023 10-Q 2024-10-02
Q2 2023 $472M -$131M -21.7% May 28, 2023 10-Q 2024-06-26
Q1 2023 $322M -$357M -52.6% Feb 26, 2023 10-Q 2024-04-03
Q4 2022 $430M -$381M -47% Nov 27, 2022 10-Q 2024-10-02
Q3 2022 $499M -$878M -63.7% Aug 28, 2022 10-Q 2023-10-05
Q2 2022 $602M -$622M -50.8% May 29, 2022 10-Q 2023-07-06
Q1 2022 $679M -$1.3B -65.6% Feb 27, 2022 10-Q 2023-04-06
Q4 2021 $811M -$687M -45.9% Nov 28, 2021 10-K 2024-01-25
Q3 2021 $1.38B +$23.5M +1.74% Aug 29, 2021 10-Q 2022-10-06
Q2 2021 $1.22B -$224M -15.5% May 30, 2021 10-Q 2022-07-07
Q1 2021 $1.97B +$1.1B +126% Feb 28, 2021 10-Q 2022-04-06
Q4 2020 $1.5B +$563M +60.2% Nov 29, 2020 10-K 2024-01-25
Q3 2020 $1.35B +$489M +56.6% Aug 23, 2020 10-Q 2021-10-06
Q2 2020 $1.45B +$588M +68.2% May 24, 2020 10-Q 2021-07-08
Q1 2020 $874M +$252M +40.4% Feb 23, 2020 10-Q 2021-04-08
Q4 2019 $935M +$221M +31% Nov 24, 2019 10-K 2023-01-25
Q3 2019 $864M +$251M +41% Aug 25, 2019 10-Q 2020-10-06
Q2 2019 $861M +$162M +23.2% May 26, 2019 10-Q 2020-07-07
Q1 2019 $623M +$31.6M +5.34% Feb 24, 2019 10-Q 2020-04-07
Q4 2018 $714M +$79M +12.4% Nov 25, 2018 10-K 2022-01-26
Q3 2018 $613M Aug 26, 2018 10-Q 2019-10-08
Q2 2018 $699M May 27, 2018 10-Q 2019-07-09
Q1 2018 $591M Feb 25, 2018 10-Q 2019-04-09
Q4 2017 $635M +$258M +68.6% Nov 26, 2017 10-K 2021-01-27
Q4 2016 $377M Nov 27, 2016 10-K 2020-01-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.